MAPK3 and lymphoma: Though direct association of the role of ERK1/2-ELK1 signaling with metastasis in lymphoma has not been made, given its capacity to promote transcriptional programs that promote tumor growth and tumor aggressiveness, one might consider analogous processes are operating in the case of CTCL.